JAMA Network
About the Study: In this cohort study using nationwide Medicaid data, Black pregnant females with opioid use disorder (OUD) had higher discontinuation rates than White females for buprenorphine treatment during pregnancy and through 1 year postpartum, with less pronounced disparities for methadone. Findings suggest persistent racial and ethnic inequities in treatment retention during and after pregnancy.
JAMA+ Women's Health
Explore JAMA+ Women's Health for more Women's Health research, commentary, multimedia, and resources. Led by Editor in Chief Linda Brubaker, MD, JAMA+ Women's Health is a curated source of trusted clinical information that advances health care for women worldwide. Dr Brubaker is also a JAMA Deputy Editor.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
